A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Ontology highlight
ABSTRACT: 20 participants are expected to be enrolled for this open,Single-armed clinical trial to evaluate the safety and efficacy of the recombinant herpes simplex virus Ⅰ, R130 in patients with advanced solid tumors.
DISEASE(S): Gynecologic Cancer,Lung Cancer,Carcinoma,Sarcoma,Colorectal Cancer,Gastric Cancer,Liver Cancer,Pancreatic Cancer,Breast Cancer
PROVIDER: 60186 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA